Should You Buy Nike Stock Before Oct. 1?

Nike is scheduled to report fiscal Q1 2027 earnings on Oct. 1 after its shares lost roughly 50% over the past 12 months. Softer year-ago comparisons and low investor expectations could support a near-term upside surprise, but the article argues that Nike's turnaround under CEO Elliott Hill remains underwhelming. At about 21x estimated forward earnings versus 20x for the S&P 500, the stock is not viewed as sufficiently cheap to justify buying ahead of results without stronger evidence of sustained growth.

Analysis

The setup is less about a mechanical beat against depressed comparables than whether NKE can show evidence that demand is improving without buying it through promotions. A revenue beat accompanied by higher markdowns, wholesale concessions, or deteriorating gross margin would likely be sold; the market needs proof that product-cycle investment and channel rebalancing can lift full-price sell-through. That makes North America inventory turns, gross margin, and FY27 operating-margin cadence more decision-useful than headline EPS.

Competitive read-through is asymmetric. If Nike restores shelf space and marketing intensity through wholesale partners, adidas (ADS.DE), Puma (PUM.DE), Deckers (DECK) and On Holding (ONON) face incremental share pressure in core running/lifestyle doors over the next 6-18 months. Conversely, another weak guide would reinforce that challenger brands are retaining consumer relevance, favoring ONON and DECK; Foot Locker (FL) is a high-beta beneficiary only if Nike's wholesale reset translates into traffic rather than promotional inventory.

Consensus may be underestimating the valuation trap: a modest quarterly improvement does not justify multiple expansion if the turnaround requires sustained demand creation and margin investment. With NKE valued near the broad-market forward multiple despite structurally lower growth, upside after a beat is likely capped unless management raises medium-term margin and revenue confidence. The near-term skew remains negative because guidance credibility—not the quarter—sets the stock reaction.

For the next 1-3 months, watch channel checks on holiday sell-through, China demand, and digital conversion; these determine whether the October report is the start of estimate revisions or merely a low-bar beat. A constructive thesis is falsified by gross-margin pressure despite lower inventory, a reduced full-year outlook, or evidence that wholesale growth is promotion-led. Over 6-18 months, a durable rerating requires sequential market-share gains in running and lifestyle categories plus operating-margin recovery without a renewed inventory build.

Key Decisions for Investors

• Maintain underweight NKE into Oct. 1; do not buy a low-bar earnings beat absent improved gross-margin and full-year operating-margin guidance. Reassess long exposure only if management demonstrates clean full-price demand and raises FY27 outlook.
• Use a post-results pair rather than outright beta: long ONON / short NKE for 1-3 months if NKE reports weak guidance, elevated promotions, or soft China trends. Exit if NKE raises annual revenue and margin expectations while ONON's growth guide remains intact; target approximately 10-15% relative return with a 5-7% stop on the pair.
• If implied volatility is elevated ahead of results, favor defined-risk NKE put spreads dated 4-8 weeks after earnings over naked shorts. The thesis is a guidance-led downside move; cap risk because a credible wholesale/inventory improvement could generate a sharp short-covering rally.
• Set an alert on FL following results: consider a tactical long only if Nike confirms wholesale sell-through improvement without heavier discounting. Missing data is retailer inventory and door-level traffic; without that confirmation, FL is not a clean read-through trade.